We Set the Tone for Clinical Trial Inclusivity

Cena Research Institute (CRI) is a trailblazer in inclusive clinical research, prioritizing underrepresented populations and rare disease studies. Through diverse, multilingual support, CRI ensures that every voice is part of advancing healthcare.

Inclusive clinical trials for underrepresented populations, rare disease states, and multilingual support.

Who We Are

Cena Research Institute (CRI), a leading research institute in Houston, TX, specializes in inclusive clinical trials that advance medical research for diverse communities. Our multidisciplinary team, including MDs, PhDs, postgraduates, medical students, and undergraduates, collaborates to design and conduct studies that prioritize inclusivity and equity.

Since our founding in 2014, CRI has been dedicated to transforming clinical research through pioneering work in pharmaceuticals, medical technology, and rare diseases—ensuring broader access to healthcare advancements for groups often underrepresented in medicine.

Our Research

We conduct in-depth research across a spectrum of medical fields, advancing both practical and academic knowledge with a commitment to inclusive and innovative trials.

Medical Technology (MedTech) Research

We explore and evaluate cutting-edge medical technologies, developing and testing solutions designed for real-world applications with a focus on devices that address the needs of diverse communities.

Pharmaceutical
Trials

Our pharmaceutical research brings new treatments to light, with trials aimed at safe, effective therapies that address the unique needs of underserved populations.

Research & Development (R&D)

Our R&D efforts drive continuous innovation, covering a wide array of health conditions and advancing medical knowledge for a broader, inclusive impact.

Case Studies & Projects

Our impactful case studies showcase CRI’s dedication to improving health outcomes across demographics, from hypertension and cardiovascular health to rare genetic disorders.

Case Study: Valencell

Valencell partnered with Cena Research Institute (CRI) to conduct two comprehensive studies focused on hypertension, exploring solutions for both hypertensive and hypotensive conditions in diverse patient populations.

Study 1: Hypertension Trial

This study aimed to understand the varying effects of hypertension across age and weight demographics, contributing valuable insights to personalized hypertensive treatments.

Study 2: Hypertensive and Hypotensive Trial

This study provided critical data on the impacts of extreme blood pressure levels, enhancing the development of targeted interventions for managing both high and low blood pressure.

Our Strategic Technology Research Partners

We collaborate with top leaders in medical technology, pharmaceuticals, and academia to drive research advancements that champion inclusivity and accessible healthcare. Meet our partners:

Start Your Journey with CRI

CRI offers various pathways to get involved in meaningful, groundbreaking research, whether you’re a student, researcher, or participant. Our internship and career opportunities invite passionate individuals to join a team focused on creating lasting change in medical research.